Berlin. gematik published the specification for ePA version 3.1 in advance on Monday. This includes the technical specifications for the expansion of the digitally supported medication process (dgMP) – the interaction of the medication list and medication plan -, additional relevant information in the context of drug therapy safety (ATMS) and the transfer of data from ePA to the research data center (FDZ).
Pre-publication begins the comment phase, in which gematik shareholders, among others, submit their comments on the specification. The final specification is scheduled to be published in mid-August. (eb)